Company Filing History:
Years Active: 2002-2003
Title: **Innovative Contributions of Jeffry David McGolrick in Pharmaceutical Synthesis**
Introduction
Jeffry David McGolrick is a notable inventor based in Ontario, California, recognized for his significant contributions to the field of pharmaceuticals. With three patents to his name, McGolrick has made substantial advancements in the synthesis of key compounds, demonstrating his expertise and commitment to improving pharmaceutical processes.
Latest Patents
Among Jeffry McGolrick's latest innovations is his patent for the synthesis of histamine dihydrochloride. This invention outlines a two-step non-enzymatic synthetic method for preparing pharmaceutical-grade histamine dihydrochloride. The process involves the non-enzymatic decarboxylation of histidine, followed by the step-wise conversion of the decarboxylated product into its dihydrochloride salt form. The patent emphasizes that the final product must contain less than 0.8% L-histidine HCl monohydrate, 0.1% individual chromatographic impurities, and 2% total impurities to qualify for pharmaceutical use.
Career Highlights
Jeffry David McGolrick works at Maxim Pharmaceuticals, Inc., where his inventive solutions have contributed to the company’s advancements in drug development. His innovative approach to pharmaceutical synthesis has played a pivotal role in enhancing the efficiency and quality of pharmaceutical products.
Collaborations
In his professional journey, McGolrick has collaborated with esteemed colleagues such as Wen-Lung Yeh and Casimir Antczak. Their collective efforts have enabled the exploration of cutting-edge techniques in pharmaceutical synthesis, fostering an environment of innovation and teamwork.
Conclusion
Jeffry David McGolrick stands out as a significant figure in the realm of pharmaceutical inventions, particularly with his patented synthesis of histamine dihydrochloride. His commitment to innovation, combined with collaboration with talented peers, exemplifies the importance of research and development in the pharmaceutical industry. As he continues to contribute his expertise, the impact of his work will undoubtedly lead to further advancements in healthcare solutions.